Guerre-Millo M
Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Paris, France.
J Endocrinol Invest. 2002 Nov;25(10):855-61. doi: 10.1007/BF03344048.
It is now widely accepted that white adipose tissue (WAT) secretes a number of peptide hormones, including leptin, several cytokines, adipsin and acylation-stimulating protein (ASP), angiotensinogen, plasminogen activator inhibitor-1 (PAI-1), adiponectin, resistin etc., and also produces steroids hormones. This newly discovered secretory function has shifted our view of WAT, which is no longer considered only an energy storage tissue but a major endocrine organ, at the heart of a complex network influencing energy homeostasis, glucose and lipid metabolism, vascular homeostasis, immune response and even reproduction. Virtually all known adipose secreted proteins are dysregulated when the WAT mass is markedly altered, either increased in the obese state or decreased in lipoatrophy. This strongly implicates adipose-secreted products in the ethiopathology and/or complications of both obesity and cachexia. This review discusses the physiological relevance of adipose secretion by focusing on protein and steroid hormones. Regulation of WAT secretion by the major regulatory factors impinging on the adipocytes, i.e. insulin, glucocorticoids, catecholamines and thiazolidinediones (TZD) will be addressed. The rationale for therapeutic strategies aimed at compensating adverse effects resulting from overproduction or lack of a specific adipose secretory product will be discussed.
现在人们普遍认为,白色脂肪组织(WAT)会分泌多种肽类激素,包括瘦素、多种细胞因子、脂肪酶和酰化刺激蛋白(ASP)、血管紧张素原、纤溶酶原激活物抑制剂-1(PAI-1)、脂联素、抵抗素等,并且还能产生类固醇激素。这一最新发现的分泌功能改变了我们对白色脂肪组织的看法,它不再仅仅被视为一个能量储存组织,而是一个主要的内分泌器官,处于影响能量稳态、葡萄糖和脂质代谢、血管稳态、免疫反应甚至生殖的复杂网络的核心位置。实际上,当白色脂肪组织的质量显著改变时,无论是在肥胖状态下增加还是在脂肪萎缩时减少,几乎所有已知的脂肪分泌蛋白都会失调。这有力地表明脂肪分泌产物与肥胖和恶病质的病因学和/或并发症有关。本综述通过聚焦蛋白质和类固醇激素来讨论脂肪分泌的生理相关性。将探讨影响脂肪细胞的主要调节因子,即胰岛素、糖皮质激素、儿茶酚胺和噻唑烷二酮类(TZD)对白色脂肪组织分泌的调节作用。还将讨论旨在补偿因特定脂肪分泌产物过量产生或缺乏而导致的不良影响的治疗策略的基本原理。